In 1998, the Department of Defense (DoD) began a program of mandatory immunization against anthrax for all military personnel. As the program proceeded, however, some military personnel and their families raised concerns about the safety and efficacy of the anthrax vaccine. Acknowledging both the need to protect military personnel and the concerns about the anthrax vaccine, congress directed the Centers for Disease Control and Prevention (CDC) to carry out a research program on its safety and efficacy. To assist in the development of this program, CDC requested the Institute of Medicine (IOM) to convene a committee to review the completeness and appropriateness of the research program. In An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program, the committee makes an overall assessment of the CDD research plan and reviews the specific studies proposed by CDC in the three areas of efficacy, safety and acceptability. The committee also notes additional research needs that became evident following the bioterrorist events of 2001 and makes recommendations about the leadership of the research program.
Table of Contents
|3 The CDC Anthrax Vaccine Research Plan||33-42|
|4 Proposed Studies on the Efficacy of the Anthrax Vaccine||43-55|
|5 Proposed Studies on the Safety of the Anthrax Vaccine||56-81|
|6 Proposed Studies on the Acceptability of the Anthrax Vaccine||82-90|
|7 Summary Assessment of the CDC Anthrax Vaccine Research Plan||91-100|
|Appendix A Biographical Sketches||101-104|
|Appendix B Information-Gathering Meeting Agendas||105-112|
|Appendix C Anthrax Vaccine Safety & Efficacy Research Plan||113-136|
|Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible||137-148|
|Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program||149-152|
|Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1||153-154|
|Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1||155-160|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program...